Drug Trial Radar · NCT07569042
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma
Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Apr 20, 2026
Primary completion
Sep 30, 2029
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Novelwise Pharmaceutical CorporationIndustry
- Sponsor type
- Industry
- First posted
- May 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial is a rollover study designed to provide continued access to NBM-BMX and temozolomide (TMZ) for eligible participants with newly diagnosed glioblastoma who have completed the designated treatment in Study NBM-BMX-003 (the parent study), and to evaluate the long-term safety and efficacy of NBM-BMX administered in combination with TMZ.
Conditions
- Malignant Neoplasm of Brain
Interventions
NBM-BMX CapsuleDrug
Each capsule contains 100 mg of the active ingredient.
TemozolomideDrug
Temodal will be administered orally at a 75 mg/m2 dose daily during concomitant therapy. In the maintenance period, days 1-5 of each cycle will be administered 150-200 mg/m2.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency, types, severity, and relationship to NBM-BMX of adverse events (AEs)Time frame: Through study completion, an average of 1 year.
- Progression-free survival (PFS) and overall survival (OS)Time frame: Through study completion, an average of 1 year.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan · Not yet recruiting
Taichung Veterans General Hospital
Taichung, Taiwan · Not yet recruiting
Linkou Chang-Gung Memorial Hospital
Taoyuan City, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.